Tradestie Institutional Equity Comparison Engine
SGMO vs ABPWW โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
SGMO Overall Edge
SGMO Captures Institutional Edge (4โ0 Pillars ยท 10โ0 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Sangamo Therapeutics, Inc. Common Stock (SGMO) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, SGMO trades at 0.4x Forward P/E with -175.5% operating margin (+88.4% YoY revenue) versus ABPWW at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, SGMO sits in UNCLASSIFIED (71st %ile IV; Dealer Gamma Walls on Pro) against ABPWW sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
SGMO
SGMO 0.4x vs ABPWW N/M Fwd P/E
Growth & Margin Winner
SGMO
Op Margin -175.5% vs N/A ยท YoY +88.4% vs N/A
Momentum & Technical Winner
SGMO
1Y -76.0% vs -80.8% ยท 52W Pos 9% vs 0%
Options & Structure Winner
SGMO
UNCLASSIFIED (71st %ile IV) vs UNCLASSIFIED (N/A IV)
SGMO
NASDAQ
Sangamo Therapeutics, Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$0.18
+31.56% 1D
Market Cap
$55.9M
1M Return
-40.82%
1Y Return
-76.04%
Forward P/E
0.4x
Unified AI Score
52.0 / 100
HOLD
Tech 25.0
Fund 46.0
Flow 65.0
Mom 60.0
ABPWW
NASDAQ
Abpro Holdings, Inc. Warrant
Institutional Equity
$0.01
+0.0% 1D
Market Cap
N/A
1M Return
-17.86%
1Y Return
-80.83%
Forward P/E
N/M
Unified AI Score
45.0 / 100
HOLD
Tech 50.0
Fund 50.0
Flow 50.0
Mom 50.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
SGMO -76.04%
ABPWW -80.83%
Spread: +8.96 pp (ABPWW Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
SGMO TTM Op. Margin: -175.5%
ABPWW TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on SGMO vs ABPWW. Trailing 12-month operating profitability (SGMO -175.5% vs ABPWW N/A) and valuation multiples (SGMO 0.4x vs ABPWW N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | SGMO | ABPWW | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $55.9M | N/A | Larger Scale | SGMO |
| Trailing P/E Ratio Valuation | 0.4x | N/M | Lower Multiple | SGMO |
| Forward P/E Ratio Valuation | 0.4x | N/M | Lower Multiple | SGMO |
| Revenue Growth (YoY) Growth | +88.4% | N/A | Higher Growth | SGMO |
| Operating Margin (TTM) Profitability | -175.5% | N/A | Higher Margin | SGMO |
| Net Profit Margin Profitability | 0.0% | N/A | Higher Margin | SGMO |
| Return on Equity (ROE) Capital Efficiency | -2891.8% | N/A | Higher ROE | SGMO |
| 52-Week Range Position Momentum | 9% ($0โ$1) | 0% ($0โ$0) | Stronger Trend | SGMO |
| Beta / 30D Volatility Risk Regime | 1.49ฮฒ ยท 206% Vol | -1.56ฮฒ ยท 265% Vol | Lower Realized Risk | SGMO |
| Unified Institutional Score Composite Signal | 52.0 / 100 (HOLD) | 45.0 / 100 (HOLD) | Higher Composite | SGMO |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full SGMO vs ABPWW Buy Guide
SGMO
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
71st %ile
IV Regime
Elevated (60thโ80th %ile)
ABPWW
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither SGMO nor ABPWW registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.